Luiza Kanczuga-Koda Selected Research

Luiza Kanczuga-Koda Research Topics

Disease

34	Neoplasms (Cancer) 10/2019 - 12/2003
14	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 12/2004
11	Breast Neoplasms (Breast Cancer) 11/2010 - 04/2004
8	Lymphatic Metastasis 06/2014 - 04/2004
7	Carcinogenesis 02/2018 - 01/2005
7	Adenocarcinoma 02/2018 - 01/2005
7	Neoplasm Metastasis (Metastasis) 06/2014 - 03/2006
7	Hypoxia (Hypoxemia) 01/2013 - 03/2006
5	Endometrioid Carcinoma 02/2018 - 12/2008
4	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 01/2007
3	Carcinoma (Carcinomatosis) 01/2014 - 01/2010
2	COVID-19 01/2021 - 01/2020
2	Adenoma (Adenomas) 01/2010 - 08/2007
2	Obesity 08/2007 - 03/2006
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 10/2019
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2006
1	Mouth Neoplasms (Oral Cancer) 12/2006
1	Squamous Cell Carcinoma of Head and Neck 12/2006
1	Papilloma (Papillomatosis) 12/2004
1	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 08/2004

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 02/2018 - 12/2003
8	Estrogen ReceptorsIBA 02/2018 - 04/2004
8	ConnexinsIBA 06/2014 - 03/2005
6	Connexin 43 (Connexin43)IBA 01/2015 - 08/2005
6	LeptinIBA 06/2010 - 03/2006
5	Estrogen Receptor alphaIBA 06/2010 - 04/2004
5	Leptin ReceptorsIBA 06/2010 - 03/2006
4	Cadherins (E-Cadherin)IBA 02/2018 - 07/2010
4	Connexin 26IBA 07/2010 - 03/2005
3	Apoptosis Regulatory ProteinsIBA 01/2015 - 08/2004
3	Estrogens (Estrogen)FDA Link 08/2011 - 04/2004
3	Estrogen Receptor betaIBA 06/2010 - 04/2004
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2006 - 12/2004
3	Biotin (Vitamin H)FDA Link 12/2006 - 12/2004
3	Peroxidase (Myeloperoxidase)IBA 12/2006 - 12/2004
3	AvidinIBA 12/2006 - 12/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 10/2009
2	Erythropoietin FDA Link 01/2013 - 07/2010
2	beta CateninIBA 09/2010 - 07/2010
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2010 - 01/2009
2	Glucose (Dextrose)FDA LinkGeneric 06/2010 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 06/2010 - 03/2006
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2009 - 01/2007
2	Insulin (Novolin)FDA Link 12/2006 - 03/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Insulin Receptor Substrate ProteinsIBA 07/2020
1	Ferritins (Ferritin)IBA 01/2020
1	AndrogensIBA 10/2019
1	Androgen Receptors (Androgen Receptor)IBA 10/2019
1	EnzymesIBA 10/2019
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 10/2019
1	A-factor (Streptomyces)IBA 02/2018
1	CateninsIBA 06/2014
1	mucicarmineIBA 01/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2014
1	Alcian BlueIBA 01/2014
1	Hematoxylin (Haematoxylon)IBA 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2009
1	Hormones (Hormone)IBA 08/2007
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 07/2007
1	Gap Junction beta-1 ProteinIBA 01/2007
1	Hypoxia-Inducible Factor 1IBA 01/2007
1	Insulin-Like PeptidesIBA 12/2006
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	Growth Factor ReceptorsIBA 07/2005
1	Biological FactorsIBA 07/2005
1	AntibodiesIBA 03/2005
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2005
1	AntioxidantsIBA 01/2005
1	Malondialdehyde (Propanedial)IBA 01/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2005
1	VitaminsIBA 01/2005
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2004

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 11/2010 - 02/2007
3	Therapeutics 06/2010 - 04/2004
1	Neoadjuvant Therapy 07/2007